Business Operations:

Sector: Healthcare
Industry: Medical Distribution

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Revenue projections:

Investors may be wary of HSIC as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio	1.319000
forwardPE	14.170402
debtToEquity	80.733000
earningsGrowth	0.171000
revenueGrowth	0.067000
grossMargins	0.313190
operatingMargins	0.057550
trailingEps	3.430000
forwardEps	5.989950

HSIC's current ratio of 1.319 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, HSIC can comfortably cover its liabilities, reflecting a strong financial outlook.
Henry Schein, Inc.'s Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
Henry Schein, Inc.'s high debt-to-equity ratio indicates a high level of leverage, meaning the company relies significantly on debt for financing. This can increase financial risk, particularly in times of economic instability or reduced profitability.
HSIC's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in HSIC's earnings potential, with forecasts indicating better financial performance than in the prior year.

Price projections:

Throughout its recent performance, Henry Schein, Inc.'s price has been consistently close to the lower range of projected values. This suggests that the company may face challenges in achieving higher valuations in the eyes of investors.

Insider Transactions:

6 HSIC transactions were recorded, when the market price was 78.91333389282227.There were 2 buy transactions of HSIC, with market price at 67.44499969482422.HSIC's current price levels have seen more sells, possibly signaling bearish sentiment. If this trend remains unchanged, the stock could experience further declines as more investors opt to sell rather than hold their positions.

Recommendation changes over time:

Analysts have maintained a buy bias for HSIC, which could prompt investors to consider the stock as a viable investment. With this positive outlook, HSIC is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.